Dare Bioscience
DARE
28 hedge funds and large institutions have $5.92M invested in Dare Bioscience in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 0.68% → 0.63% (-0.05%)
3% less funds holding
Funds holding: 29 → 28 (-1)
17% less capital invested
Capital invested by funds: $7.16M → $5.92M (-$1.24M)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$162K |
| 2 |
Renaissance Technologies
New York
|
+$148K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$380 |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$249 |
| 5 |
CSC
Caldwell Sutter Capital
Sausalito,
California
|
+$202 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$208K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$193K |
| 3 |
SAM
Soviero Asset Management
New York
|
-$135K |
| 4 |
Jane Street
New York
|
-$78.4K |
| 5 |
VF
Virtu Financial
New York
|
-$34K |
DARE Hedge Fund Activity: Q2 2023 in Review
28 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2023, worth a combined $5.92M — down 17% from $7.16M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of DARE and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $162K. The largest seller was BlackRock, cutting an estimated $208K.
- 28 institutional investors held Dare Bioscience (DARE) as of Q2 2023, down from 29 in Q1 2023.
- Funds reported $5.92M of Dare Bioscience stock for Q2 2023, down 17% quarter-over-quarter.
- 4 funds opened new Dare Bioscience positions in Q2 2023 and 5 closed out, a net change of -1 holder.
- The largest Dare Bioscience buyer in Q2 2023 was Susquehanna International Group, an estimated $162K added.
- The largest Dare Bioscience seller in Q2 2023 was BlackRock, an estimated $208K sold.
Based on aggregated 13F filings for Q2 2023.